On March 29, shares in the Escalade Inc. company were selling at $14.42.
Escalade Inc. employs 584 people and has reported $10,380,000 in income as of March 29.
In the fluctuating stock market, healthcare and technology stocks are viewed as the safest bets for long-term gains.
Besty Kuekcer with Benzinga.com said healthcare-related stocks, such as hospital conglomerates and insurance companies, have weathered numerous economic crises and still make a profit, meaning they’re a stable investment.
While technology stocks can be more risky, given the boom-bust nature of new tech companies, Kuecker recommended a diverse portfolio of tech companies to strike it big when companies succeed or sell to other larger companies.
For short-term investments, Kuecker recommended “consumer discretionary” stocks, which are sensitive to economic changes but can rise greatly on the back of a strong economy.
Nothing in this article is to be assumed as financial advice.
Individual companies can have several different types of shares across many stock markets. It is possible for different types of shares to see different results on the market.
| Company Name | % of Change in Last Year | Selling Price |
|---|---|---|
| Edgemode Inc | 17,500% | $0.0176 |
| Biomea Fusion Inc. | 625.34% | $32.35 |
| Ardelyx Inc. | 337.38% | $4.68 |
| 89Bio Inc. | 321.6% | $15.81 |
| Findit Inc. | 303.54% | $0.0799 |
| Cabaletta Bio Inc. | 255.4% | $7.57 |
| Aehr Test Systems | 241.92% | $37.85 |
| Bellerophon Therapeutics Inc. | 216.53% | $7.66 |
| Enliven Therapeutics Inc | 205.74% | $23.97 |
| Elf Beauty Inc. | 203.93% | $80.42 |
| Cannabis Suisse Corp. | 187.5% | $0.069 |
| CVD Equipment Corp. | 185.24% | $12.95 |
| Atlas Lithium Corp | 180.32% | $17.45 |
| Cymabay Therapeutics Inc. | 170.06% | $8.75 |
| Akero Therapeutics Inc. | 164.26% | $40.3 |
| Earth Science Tech Inc. | 163.91% | $0.037 |
| Compass Therapeutics Inc. | 153.97% | $3.2 |
| CECO Environmental Corp | 149.91% | $14.17 |
| Asure Software Inc. | 137.72% | $14.62 |
| Assertio Holdings Inc. | 135.96% | $6.3 |
| Vita Coco Company Inc. | 122.36% | $19.99 |
| Arcellx Inc | 121.75% | $31.09 |
| Concrete Leveling Systems Inc. | 106.67% | $2.48 |
| Catalyst Pharmaceuticals Inc. | 106.17% | $16.72 |
| Digital Brand Media & Marketing Group Inc. | 104% | $0.0051 |
| Blue Dolphin Energy Co. | 102.53% | $1.76 |
| Flux Power Holdings Inc. | 101.61% | $5.02 |
| Amylyx Pharmaceuticals Inc | 95.51% | $29.19 |
| Bel Fuse Inc. | 94.58% | $35.55 |
| Bel Fuse Inc. | 94.58% | $35.55 |
| Alliance Creative Group Inc. | 94.12% | $0.33 |
| Bowman Consulting Group Ltd. | 91.72% | $28.95 |
| Agilysys Inc. | 91.3% | $80.04 |
| Aldeyra Therapeutics Inc. | 88.25% | $9.45 |
| Aldeyra Therapeutics Inc. | 88.25% | $9.45 |
| Astria Therapeutics Inc. | 87.55% | $13.11 |
| Actinium Pharmaceuticals Inc. | 83.3% | $9.22 |
| Adeia Inc | 81.96% | $8.49 |
| Burzynski Research Institute Inc. | 78.75% | $0.0358 |
| ADMA Biologics Inc. | 78.69% | $3.27 |
| Cadiz Inc. | 75.54% | $4.09 |
| Geron Corp. | 74.22% | $2.23 |
| Bion Environmental Technologies Inc. | 73.8% | $1.56 |
| Ambac Financial Group Inc. | 73.12% | $14.94 |
| American Realty Investors Inc. | 72.28% | $25.85 |
| Aaon Inc. | 68.92% | $94.78 |
| BrightRock Gold Corp. | 68.73% | $0.15 |
| BioVie Inc. | 67.63% | $8.13 |
| Anixa Biosciences Inc. | 66.97% | $4.65 |
| Deciphera Pharmaceuticals Inc. | 65.24% | $15.45 |